Times Now · Healthcare · 2026-09-03
Ivermectin is a widely used antiparasitic medicine
Ivermectin is a widely used antiparasitic medicine. It is attracting renewed attention in cancer research. Lab and animal studies suggest it may interfere with several biological pathways involved in tumour growth. Despite these intriguing findings, ivermECTin is not an approved cancer treatment. Researchers say much more human evidence is needed before its potential can be established. A 2025 systematic review examined the possibility of repurposing iver mectin for cancer. Early research suggests ivermectin may target cancer pathways, but promising laboratory and animal findings require rigorous human clinical trials to confirm effectiveness. , Health, Times Now
Why it matters. Understanding the distinction between preliminary laboratory findings and approved treatments is crucial for evaluating emerging cancer therapies safely.
Read original on Times Now Get the app
Licensed summary · LicensedSummary
Related briefs
- NCOPS, Bengaluru prepares Pharmacy graduates for industry-ready careers in the
- 7-yr-old dies, 53 others ill after taking anti-malaria tablets in AP
- New guidelines from the American Stroke Association recommend that stroke
- School attendance is emerging as a key, overlooked factor in the battle
- Trying to optimise sleep in this way is called "sleepmaxxing" Take it too far